Trial intelligence / Profile preview

Sedative effect of remifentanil in senile cataract surgeries

IRCT201111268201N1Phase 2Completed

Sponsor
Tehran University of Medical Sciences
Start
Dec 2010
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of remifentanil in cataract, sponsored by Tehran University of Medical Sciences. Started Dec 2010; status: completed.

02

Drugs

remifentanil
03

Conditions

cataract

Beyond the preview

Go deeper on IRCT201111268201N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201111268201N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call